Lightbeam Health Solutions Reports $444 Million in ACO Savings for 2024

October 21, 2025
Lightbeam Health Solutions announced that its clients in the Medicare Shared Savings Program generated over $444 million in gross savings during 2024, outperforming national averages in both cost reduction and quality scores.

Lightbeam Health Solutions generated more than $444 million in gross savings for Accountable Care Organizations (ACOs) participating in the Medicare Shared Savings Program (MSSP) in 2024, announced in a press release. Lightbeam clients achieved an average savings rate of 5.02%, compared to 4.72% for non-Lightbeam ACOs, and produced an average of $16.4 million in savings per ACO.

The company reported that its clients also maintained higher quality scores, averaging 83.02% versus 81.83% for non-Lightbeam participants. ACOs that used Lightbeam’s Advisory Services achieved the strongest results, averaging $16.6 million in savings per ACO and nearly two percentage points higher quality scores than peers.

Lightbeam stated that its advisory team works closely with ACOs to improve performance through data-driven strategies, including remote patient monitoring, artificial intelligence, and targeted care gap interventions. The company has now surpassed $3 billion in gross MSSP savings and $5 billion in total value-based care savings since the program’s inception.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

10/21
Hyro Raises $45 Million to Expand AI Agents for Healthcare
10/21
DrugBank Appoints Lisa Downey as CEO, Co-Founder Mike Wilson Moves to Chief Product Role
10/21
Brook.ai Names Former Teladoc COO Mike Waters as Chairman of the Board
10/21
Tri-City Cardiology Expands AI Partnership with Basata
10/21
Family Health Choice Partners with MediKarma to Add AI Health Guidance

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like